Welcome to our dedicated page for TITAN MEDICAL ORD news (Ticker: TMDIF), a resource for investors and traders seeking the latest updates and insights on TITAN MEDICAL ORD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TITAN MEDICAL ORD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TITAN MEDICAL ORD's position in the market.
Titan Medical Inc. (TSX: TMD; OTC: TMDIF) has announced a third amendment to its amalgamation agreement with Conavi Medical Inc., originally dated March 17, 2024. The key changes include:
- Extending the completion deadline to October 10, 2024
- Reducing the minimum concurrent financing from $15 million to $7.5 million
- Lowering Titan's required minimum net cash from US$5 million to US$2 million
Additionally, Titan has received approval from the Toronto Stock Exchange to extend its Annual General and Special Meeting of Shareholders to September 30, 2024. This extension allows more time to finalize the proposed merger and avoid potential duplication of costs associated with multiple meetings.
Titan Medical has entered into a second amending agreement with Conavi Medical, modifying the timeline for their proposed merger. Key dates have been extended, including the completion of the merger by September 30, 2024, and the commitment for concurrent financing by August 12, 2024. Additionally, Titan is seeking an extension from the Toronto Stock Exchange to hold its Annual General Meeting by September 30, 2024. This extension aims to reduce costs and provide more time to finalize the merger, which requires shareholder approval.
Titan Medical (TSX: TMD; OTC: TMDIF) has amended its amalgamation agreement with Conavi Medical, altering completion timelines for their merger. The new deadlines include:
- August 30, 2024, for the transaction completion.
- June 21, 2024, for financing and Conavi's financial statements.
- June 28, 2024, for mailing AGM information circulars.
- July 26, 2024, for holding AGMs.
Additionally, Conavi has advanced $150,000 to Titan to cover extension-related expenses. Titan has also received an extension from the Toronto Stock Exchange to hold its Annual General Meeting by July 31, 2024, to finalize the merger details.
Titan Medical (TMDIF) updated on its planned merger with Conavi Medical, as per the definitive Amalgamation Agreement dated March 17, 2024.
The merger involves delisting from TSX and listing on TSXV, with required submissions to TSXV currently underway.
A joint management information circular, needing TSXV approval, will be mailed to shareholders before Titan's annual meeting for their approval.
Conavi is also raising a minimum of $15M through subscription receipts convertible into shares before the merger completion.
Further details are available on SEDAR.
Titan Medical Inc. reported financial results for the first quarter of 2024, including recent activities such as entering into an amalgamation agreement with Conavi Medical Inc., settling a contractual dispute, and hosting a Q&A session with shareholders. The company expects to delist its common shares from the Toronto Stock Exchange and list them on the TSX Venture Exchange as part of the transaction. Financial highlights showed a decrease in cash and working capital, a recovery of R&D expenses, and a decrease in general and administrative expenses compared to the previous year.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.